TrialThe oncologist2017

Neoadjuvant Therapy with Weekly Nanoparticle Albumin-Bound Paclitaxel for Luminal Early Breast Cancer Patients: Results from the NABRAX Study (GEICAM/2011-02), a Multicenter, Non-Randomized, Phase II Trial, with a Companion Biomarker Analysis.

Miguel Martín et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.